These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 8871628)
41. IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. Peçanha LM; Snapper CM; Lees A; Yamaguchi H; Mond JJ J Immunol; 1993 Apr; 150(8 Pt 1):3215-23. PubMed ID: 8468466 [TBL] [Abstract][Full Text] [Related]
42. Reciprocal regulation of mucosal surface IgA+ B cells by Ig receptor cross-linking and CD40 ligand. Ehrhardt RO; Gray B; Duchmann R; Inman JK; Strober W J Immunol; 1996 Aug; 157(4):1397-405. PubMed ID: 8759719 [TBL] [Abstract][Full Text] [Related]
43. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. Kindler V; Zubler RH J Immunol; 1997 Sep; 159(5):2085-90. PubMed ID: 9278293 [TBL] [Abstract][Full Text] [Related]
44. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. Corral LG; Haslett PA; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G J Immunol; 1999 Jul; 163(1):380-6. PubMed ID: 10384139 [TBL] [Abstract][Full Text] [Related]
45. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig. Schrader CE; Stavnezer J; Kikutani H; Parker DC J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186 [TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. Snapper CM; Waegell W; Beernink H; Dasch JR J Immunol; 1993 Nov; 151(9):4625-36. PubMed ID: 8409423 [TBL] [Abstract][Full Text] [Related]
47. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796 [TBL] [Abstract][Full Text] [Related]
48. A polyclonal model for B cell tolerance. I. Fc-dependent and Fc-independent induction of nonresponsiveness by pretreatment of normal splenic B cells with anti-Ig. Warner GL; Scott DW J Immunol; 1991 Apr; 146(7):2185-91. PubMed ID: 1672346 [TBL] [Abstract][Full Text] [Related]
49. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. Parry SL; Hasbold J; Holman M; Klaus GG J Immunol; 1994 Mar; 152(6):2821-9. PubMed ID: 7511629 [TBL] [Abstract][Full Text] [Related]
50. B cell early response gene expression coupled to B cell receptor, CD40 and interleukin-4 receptor co-stimulation: evidence for a role of the egr-2/krox 20 transcription factor in B cell proliferation. Newton JS; Li J; Ning ZQ; Schoendorf DE; Norton JD; Murphy JJ Eur J Immunol; 1996 Apr; 26(4):811-6. PubMed ID: 8625972 [TBL] [Abstract][Full Text] [Related]
51. Ligation of CD40 influences the function of human Ig-secreting B cell hybridomas both positively and negatively. Bergman MC; Attrep JF; Grammer AC; Lipsky PE J Immunol; 1996 May; 156(9):3118-32. PubMed ID: 8617932 [TBL] [Abstract][Full Text] [Related]
52. CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells. Kwekkeboom J; De Boer M; Tager JM; De Groot C Immunology; 1993 Jul; 79(3):439-44. PubMed ID: 7691726 [TBL] [Abstract][Full Text] [Related]
53. Regulation of B cell growth and differentiation via CD21 and CD40. Axcrona K; Gray D; Leanderson T Eur J Immunol; 1996 Sep; 26(9):2203-7. PubMed ID: 8814268 [TBL] [Abstract][Full Text] [Related]
54. Involvement of the interleukin-2 receptor gamma subunit in interleukin-4-dependent activation of mouse hematopoietic cells and splenic B cells. Watanabe S; Kondo M; Takatsu K; Sugamura K; Arai K Eur J Immunol; 1995 Jan; 25(1):126-31. PubMed ID: 7843221 [TBL] [Abstract][Full Text] [Related]
55. A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Friend SL; Hosier S; Nelson A; Foxworthe D; Williams DE; Farr A Exp Hematol; 1994 Mar; 22(3):321-8. PubMed ID: 8112430 [TBL] [Abstract][Full Text] [Related]
57. Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody. Mond JJ; Finkelman FD; Sarma C; Ohara J; Serrate S J Immunol; 1985 Oct; 135(4):2513-7. PubMed ID: 3928753 [TBL] [Abstract][Full Text] [Related]
58. Heterogeneity of mouse B lymphocytes: studies using in vitro response to lipopolysaccharide. Lamelin JP; Vassalli P Ann Immunol (Paris); 1975; 126(5-6):523-39. PubMed ID: 132134 [TBL] [Abstract][Full Text] [Related]
59. Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation. Zamorano J; Rivas D; Gayo A; Mozo L; Gutiérrez C Immunology; 1995 Jun; 85(2):241-7. PubMed ID: 7642212 [TBL] [Abstract][Full Text] [Related]
60. The acquisition of cytokine responsiveness by murine B cells: a role for antigen and IL-5 in the induction of IL-2 receptors. Poudrier J; Owens T Immunology; 1994 Mar; 81(3):373-80. PubMed ID: 8206511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]